Home > Insider Trading > Filing (0001192482-15-000206)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1267565	Collegium Pharmaceutical Inc	COLL	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1018534	D Alan Frazier	C/O Frazier Healthcare Vi, L.p. 601 Union Street, Suite 3200 Seattle WA 98101	No	No	Yes	No
1341382	N James Topper	C/O Frazier Healthcare Vi, L.p. 601 Union Street, Suite 3200 Seattle WA 98101	No	No	Yes	No
1344203	J Nader Naini	C/O Frazier Healthcare Vi, L.p. 601 Union Street, Suite 3200 Seattle WA 98101	No	No	Yes	No
1456654	Fhm Vi, L.l.c.	601 Union Street, Suite 3200 Seattle WA 98101	No	No	Yes	No
1456655	Fhm Vi, L.p.	601 Union Street, Suite 3200 Seattle WA 98101	No	No	Yes	No
1456656	Frazier Healthcare Vi, L.p.	601 Union Street, Suite 3200 Seattle WA 98101	No	No	Yes	No
1531105	R Nathan Every	C/O Frazier Healthcare Vi, L.p. 601 Union Street, Suite 3200 Seattle WA 98101	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-05-12	582,490	$0.00	582,490	No	4	C	Direct
Common Stock	Acquisiton	2015-05-12	222,231	$0.00	804,721	No	4	C	Direct
Common Stock	Acquisiton	2015-05-12	392,113	$0.00	1,196,834	No	4	C	Direct
Common Stock	Acquisiton	2015-05-12	540,498	$0.00	1,737,332	No	4	C	Direct
Common Stock	Acquisiton	2015-05-12	150,000	$12.00	1,887,332	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Stock	Disposition	2015-05-12	4,019,183	$0.00	582,490	$0.00
Common Stock	Series B Convertible Stock	Disposition	2015-05-12	1,533,399	$0.00	222,231	$0.00
Common Stock	Series C Convertible Stock	Disposition	2015-05-12	2,705,585	$0.00	392,113	$0.00
Common Stock	Series D Convertible Stock	Disposition	2015-05-12	3,676,078	$0.00	540,498	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct

Footnotes

All series of Convertible Preferred Stock automatically converted into Collegium Pharmaceutical, Inc. common stock on a 1-for-6.9 basis immediately prior to the closing of the initial public offering and had no expiration date.
Reflects the conversion of preferred stock into Collegium Pharmaceutical, Inc. common stock on a 1-for-6.9 basis which became effective on May 12, 2015.
This report is filed jointly by Frazier Healthcare VI, L.P. ("FHVI"), FHM VI, L.P. ("FHM LP"), FHM VI, LLC ("FHM LLC"), Nathan Every ("Every"), Alan Frazier ("Frazier"), Patrick Heron ("Heron"), Nader Naini ("Naini") and James Topper ("Topper"). The shares are held by FHVI. The general partner of FHVI is FHM LP, a limited partnership, the general partner of which is FHM LLC. The members of FHM LLC are Every, Frazier, Naini, Heron, and Topper. These individuals share voting and investment power over the shares held by FHVI. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.